Previous | Home | EndoTODAY | List | Next


[Pathologic interpretation]

1) Grossly complete resection (by the endoscopist): ½Ã¼úÀǻ簡 Á¾¾çÀÌ ¸ðµÎ Á¦°ÅµÇ¾ú´Ù°í ÆÇ´ÜÇÏ´Â °ÍÀº complete resectionÀ¸·Î ÆÇÁ¤ÇÏ´Â ±âº»ÀÌ´Ù.

2) En-bloc resection (or complete reconstruction in piecemeal resection cases)

3) Well or moderately differentiated histology: ´Ù¸¥ Á¶°ÇÀº ¸ðµÎ complete resectionÀÌÁö¸¸ cell type¸¸ ¹®Á¦ÀÎ °æ¿ì´Â °æ°ú°üÂûÀ» ÇÏ´Â ¿¹µµ ÀÖÀ¸¹Ç·Î, ¹Ýµå½Ã staff¿Í »óÀÇÇÑ´Ù.

4) Limited to the mucosal layer: muscularis mucosa (Á¡¸·Àº epithelial layer, lamina propria, muscularis mucosaÀÇ 3 ÃþÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù) ±îÁö ħÀ±µÈ °æ¿ì´Â Á¡¸·¾ÏÀÌ´Ù. 500 micrometer (=0.5 mm)ÀÌÇÏÀÇ Á¡¸·ÇÏÃþ ħÀ±(SM1À̶ó°í ºÎ¸¥´Ù)¿¡¼­´Â º¸Åë ¼ö¼úÀ» ±ÇÇÏÁö ¾Ê°í °æ°ú°üÂûÀ» ÇÑ´Ù. 500 micrometer¸¦ ÃÊ°úÇÏ´Â °æ¿ì´Â ¿øÄ¢»ó ¼ö¼úÀ» ÇÑ´Ù. 500 micrometer ÀÌÇÏÀÇ Ä§À±ÀÌ¶óµµ Á¾¾çÀÌ 2 cm ÀÌ»óÀ̰ųª ±Ë¾çÀÌ Àְųª ±âŸ »óȲ¿¡ µû¶ó ¼ö¼úÀ» ±ÇÇϱ⵵ ÇÑ´Ù.

5) Resection margin (-): Á¡¸·¾ÏÀÌ°í lateral marginÀÌ ÇÑ µÎ ¹æÇâ¿¡¼­¸¸ ¾ç¼ºÀ̸é Ãß°¡ÀûÀÎ ESD ȤÀº ablationÀ» Çϱ⵵ ÇÑ´Ù.

6) No vascular invasion

7) No lymphatic invasion


Lymphatic involvement°¡ ÀÖ¾î ¼ö¼úÀ» º¸³½ ¿¹


[Âü°í¹®Çå]

1) Surgical outcome after incomplete ESD (»ï¼º¼­¿ïº´¿øÀÇ °æÇè, Br J Surg 2011) - The incidence of residual tumour in the surgical specimen was 24¡¤6 per cent after incomplete ESD.


[2013-8-26. ¾Öµ¶ÀÚ Áú¹®] ³»½Ã°æ ¼¼¹Ì³ª °­ÀÇ´Â Âü À¯ÀÍÇÏ¿´½À´Ï´Ù. Àúµµ ¿¹Àü¿¡ transient global amnesia°¡ ¿Â °æ¿ì¸¦ µÎ¹ø °æÇèÇÏ¿´½À´Ï´Ù. ÇѹøÀº ¼ö¸éÈÄ¿¡, ÇѹøÀº ¼ö¸é°ú »ó°ü¾øÀÌ ÀϾ °ÍÀ̾ ¹«Ã´ ´çȲÇÑ ±â¾ïÀÌ ³³´Ï´Ù. ³»½Ã°æ ÈÄ ¾à ÇÏ·ç Á¤µµÀÇ ±â¾ï¼Ò½ÇÀÌ ÀÖ¾ú°í ÀÏÁÖÀÏ µÚ¿¡µµ °Ç°­°ËÁø ³¯À» ±â¾ïÇÏÁö ¸ðÇϼ̽À´Ï´Ù. ¿Ö ±×·±ÀÏÀÌ ÀϾ´ÂÁö ¾ÆÁ÷ ¸íÈ®ÇÏÁö ¾Ê½À´Ï´Ù.

[2013-8-26. ÀÌÁØÇà ´äº¯] ÀÏÀü ³»½Ã°æ¼¼¹Ì³ª¶§ ¼³¸íµå¸° ¹Ù¿Í °°ÀÌ midazolam »ç¿ëÇÑ È¯ÀÚ°¡ ³»½Ã°æ ÀüÈĸ¦ ±â¾ïÇÏÁö ¸øÇÏ´Â °ÍÀ» postendoscopy syndromeÀ̶ó°í ÇÕ´Ï´Ù. ±×·±µ¥ midazolam ȤÀº propofolÀ» »ç¿ëÇÏÁö ¾ÊÀº ȯÀÚ¿¡¼­µµ antegrade amnesia°¡ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾à°£ ´Ù¸£Áö¸¸ ÀúÈñµµ ¼ö³â Àü ºñ½ÁÇÑ °æÇèÀ» ÇÑ ¹Ù ÀÖ½À´Ï´Ù. ´ç½Ã´Â Buscupan ¶§¹®À¸·Î »ý°¢ÇÏ¿´½À´Ï´Ù. ÇöÀç´Â BuscopanÀ» ³»½Ã°æ Àü »ç¿ëÇÏ°í ÀÖÁö ¾Ê½À´Ï´Ù¸¸...

Âü°í¹®Çå: Unexpected anterograde amnesia associated with Buscopan used as a predmedication for endocscopy (World J Gastroenterol. 2007)

Abstract: It has been known that peripheral adverse event is caused by peripheral antimuscarinic action, from hyoscine butylbromide (Buscopan; Boehringer Ingelheim, Germany) used as a premedication for endoscopy. However, symptoms or signs associated with the central nervous system are rarely reported in the field of anesthesiology and peripartum labor. This central anticholinergic syndrome is likely caused by blockade of muscarinic cholinergic receptors in the central nervous system. There is no report on Buscopan-induced central anticholinergic syndrome in endoscopy room so far. Three middle-aged females unexpectedly suffered from anterograde amnesia after intramuscular injection of hyoscine butylbromide as an antispasmodic premedication for endoscopy at our endoscopy unit in the Health Promotion Center.


¸ðµëȸ°¡ ¿ÇÀº ¸»Àϱî¿ä, ¾Æ´Ï¸é ¸ðµÒȸ°¡ ¿ÇÀº ¸»Àϱî¿ä? °æÇâ½Å¹®ÀÇ ±â»ç¸¦ ¼Ò°³ÇÕ´Ï´Ù. '´äÀº ¸ðµÒȸ'ÀÔ´Ï´Ù.

°°Àº »ê¾Çȸ¿¡ ´Ù´Ï´Â ÈĹ谡 ÀüÈ­¸¦ Çß´Ù. Åð±Ù ÈÄ ¼ÒÁÖ ÇÑÀÜÇÏÀÚ°í ÇÑ´Ù. ȽÁý¿¡¼­ ÈĹ谡 ¼ÒÁÖ¿Í ¡®¸ðµëȸ¡¯¸¦ ÁÖ¹®ÇÑ´Ù. Á÷¾÷ÀǽÄÀÌ ÅõöÇÑ(?) ±Û¾´ÀÌ°¡ ±×¿¡°Ô ¡®¸ðµëȸ¡¯´Â Ʋ¸° ¸»À̶ó´Â °Å ¾Æ´À³Ä°í ¹°¾ú´Ù. ´«ÀÌ µ¿±×·¡Áö¸é¼­ ¡®¸ðµëȸ¡¯¶ó°í ÀûÈù À½½ÄÁ¡ Â÷¸²Ç¥¸¦ ±Û¾´ÀÌ¿¡°Ô º¸¿©ÁØ´Ù. À½½ÄÁ¡ Â÷¸²Ç¥¿¡ ¡®¸ðµëȸ¡¯ ¡®¸ðµë¿ä¸®¡¯ ¡®¸ðµë±¸ÀÌ¡¯¶ó°í Àû¾î ³õÀº ½Ä´çÀÌ ¸¹´Ù. ±×·±µ¥ ÀÌ´Â À߸øµÈ ¸»ÀÌ´Ù. ¡®¸ðµÒȸ¡¯ ¡®¸ðµÒ¿ä¸®¡¯ ¡®¸ðµÒ±¸ÀÌ¡¯°¡ ¹Ù¸¥¸»ÀÌ´Ù.

¸ðµÒȸÀÇ ¡®¸ðµÒ¡¯Àº ¡®¸ðµµ´Ù¡¯¿¡¼­ À¯·¡ÇÑ ¸»ÀÌ´Ù. ¡®¸ðÀ¸´Ù¡¯ÀÇ ¿¾¸»ÀÌ ¡®¸ðµµ´Ù¡¯ÀÌ´Ù. ±×¸®°í ¡®¸ðµÎ´Ù¡¯´Â ¡®¸ðÀ¸´Ù¡¯ÀÇ ¹æ¾ðÀ̸鼭 ¡®¸ðµµ´Ù¡¯°¡ º¯ÇüµÈ ¸»ÀÌ´Ù. ¡®¸ðµÎ´Ù¡¯ÀÇ ¸í»çÇü ¡®¸ðµÒ¡¯¿¡ ¸í»ç ¡®È¸¡¯°¡ °áÇÕÇϸ鼭 Ç¥ÁØ¾î ´ëÁ¢À» ¹Þ°Ô µÈ °ÍÀÌ´Ù. ÈûÀÇ ¹æ¾ðÀÎ ¡®½É¡¯ÀÌ ¡®¹ä½É, ¹î½É, ÆȽɡ¯Ã³·³ ÇÕ¼º¾î¸¦ ÀÌ·ê ¶§ Ç¥Áؾî·Î ÀÎÁ¤¹Þ´Â °Í°ú °°Àº ³í¸®´Ù. ±¹¸³±¹¾î¿øÀº ¿À·¡Àü ¡°¡®¸ðµÒ¡¯À̳ª ¡®¸ðµë¡¯Àº µÑ ´Ù Ç¥Áؾ ¾Æ´Ï´Ù. ±×·±µ¥ ¡®¸ðµÒȸ¡¯¸¦ Ç¥Áؾî·Î ¼±ÅÃÇÏ°Ô µÈ ÀÌÀ¯´Â ¡®¸ðµÒ-¡¯À¸·Î ½ÃÀÛÇÏ´Â ¸»ÀÌ ÇöÀç Ç¥Áؾî·Î ¸¹ÀÌ ³²¾Æ Àֱ⠶§¹®¡±À̶ó°í ¹àÇû´Ù. ¸ðµÒ²É¹ç, ¸ðµÒ³¿ºñ, ¸ðµÒ¹ß, ¸ðµÒ¹ä, ¸ðµÒ¾Õ¹«¸­Ä¡±â¿Í °°Àº ¸»µéÀÌ ÀÌÀüºÎÅÍ »ç¿ëµÇ°í ÀÖ´Ù´Â Á¡ÀÌ ¡®¸ðµë¡¯À» ¹ö¸®°í ¡®¸ðµÒ¡¯À» Ç¥Áؾî·Î »ï°Ô µÈ ÀÌÀ¯¶ó´Â ¸»ÀÌ´Ù.